Amyloid beta oligomers induce impairment of neuronal insulin receptors

Cited by (590)

Items 201–300 of 590

1. Curcumin, Cardiometabolic Health and Dementia
   Yoona Kim, Peter Marshall Clifton · 2018 · International Journal of Environmental Research and Public Health
2. Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential
   Ana Marta de Matos, Maria Paula Macedo, Amélia P. Rauter · 2017 · Medicinal Research Reviews
3. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer’s disease and type 2 diabetes
   Carmen Infante‐Garcia, Juan José Ramos‐Rodríguez, Lucia Galindo-Gonzalez, Mónica Garcı́a-Alloza · 2015 · Psychoneuroendocrinology
4. The neuronal insulin receptor in its environment
   Gralle, Matthias · 2017 · Journal of Neurochemistry
5. mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis
   Deepthi Rapaka, Veera Raghavulu Bitra, Siva Reddy Challa, Paul Chukwuemeka Adiukwu · 2022 · Neurochemistry International
6. Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A
   H.-Y. Wang, Kalindi P. Bakshi, Maya Frankfurt, Andres Stucky, Marissa Goberdhan, Sanket M. Shah, L. H. Burns · 2012 · Journal of Neuroscience
7. Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer’s Disease
   Juan José Ramos‐Rodríguez, Tara L. Spires‐Jones, Amy M. Pooler, Alfonso Maria Lechuga-Sancho, Brian J. Bacskai, Mónica Garcı́a-Alloza · 2016 · Molecular Neurobiology
8. Effect of Metformin on Adult Hippocampal Neurogenesis: Comparison with Donepezil and Links to Cognition
   Sara Atito Ali Ahmed, Zahra Mahmood, Aneela Javed, Shoaib Naiyer Hashmi, Inga Zerr, Saima Zafar, Saadia Zahid · 2017 · Journal of Molecular Neuroscience
9. Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
   Reagon Karki, Alpha Tom Kodamullil, Martin Hofmann‐Apitius · 2017 · Journal of Alzheimer s Disease
10. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes
    Naoki Yamamoto, Ryo Ishikuro, Mamoru Tanida, Kenji Suzuki, Yuri Ikeda‐Matsuo, Kazuya Sobue · 2018 · Neuroscience
11. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer’s Disease Stage in APP/PS1 Mice
    Miren Ettcheto, Dmitry Petrov, Ignacio Pedrós, Norma Alva, Teresa Carbonell, Carlos Beas‐Zárate, Mercè Pallàs, Carme Auladell, Jaume Folch, Antoni Camins · 2016 · Journal of Alzheimer s Disease
12. Sorting receptor SORLA: cellular mechanisms and implications for disease
    Schmidt, Vanessa, Subkhangulova, Aygul, Willnow, Thomas E. · 2017 · Cellular and Molecular Life Sciences
13. Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer’s Disease and Melatonin
    Eduardo Spinedi, Daniel Pedro Cardinali · 2018 · Neuroendocrinology
14. Linking insulin with Alzheimer’s disease: emergence as type III diabetes
    Sara Atito Ali Ahmed, Zahra Mahmood, Saadia Zahid · 2015 · Neurological Sciences
15. The levels of water-soluble and triton-soluble Aβ are increased in Alzheimer's disease brain
    Jessica M. McDonald, Nigel J. Cairns, Lisa Taylor‐Reinwald, David M. Holtzman, Dominic M. Walsh · 2012 · Brain Research
16. Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease
    Archontia Kaminari, Nikolas Giannakas, Athina K. Tzinia, Effie C. Tsilibary · 2017 · Scientific Reports
17. Evidence for altered insulin receptor signaling in Alzheimer's disease
    Chelsea M. Griffith, Tore Eid, Gregory M. Rose, Peter R. Patrylo · 2018 · Neuropharmacology
18. Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes
    Han Cheng, Xiaokun Gang, Yujia Liu, Gang Wang, Xue Zhao, Guixia Wang · 2019 · American Journal of Physiology-Endocrinology and Metabolism
19. Insulin mediated novel therapies for the treatment of Alzheimer's disease
    Sunil Kumar Dubey, K.K. Lakshmi, Kowthavarapu Venkata Krishna, Mukta Agrawal, Gautam Singhvi, Ranendra Narayan Saha, Swarnlata Saraf, Shailendra Saraf, Rahul Shukla, Amit Alexander · 2020 · Life Sciences
20. D-Ala2GIP Facilitated Synaptic Plasticity and Reduces Plaque Load in Aged Wild Type Mice and in an Alzheimer's Disease Mouse Model
    Émilie Faivre, Christian Hölscher · 2013 · Journal of Alzheimer s Disease
21. Dysregulation of energy metabolism in Alzheimer's disease
    Yue Yuan, Gang Zhao, Yang Zhao · 2024 · Journal of Neurology
22. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease
    Katrin Morgen, Alfredo Ramı́rez, Lutz Frölich, Heike Tost, Michael M. Plichta, Heike Kölsch, Fabian Rakebrandt, Otto Rienhoff, Frank Jessen, Oliver Peters et al. · 2014 · Alzheimer s & Dementia
23. Alzheimer Amyloid Peptide Aβ42 Regulates Gene Expression of Transcription and Growth Factors
    Christian Barucker, Anette Sommer, Georg Beckmann, Murat Eravci, Anja Harmeier, Carola G. Schipke, Damian Brockschnieder, Thomas Dyrks, Veit Althoff, Paul E. Fraser et al. · 2015 · Journal of Alzheimer s Disease
24. Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans
    Roongpetch Keowkase, Marwa A. Aboukhatwa, Yuan Luo · 2010 · Neuropharmacology
25. Nicotinic Receptors, Amyloid-β, and Synaptic Failure in Alzheimer’s Disease
    Sofia Jürgensen, Sergio Teixeira Ferreira · 2009 · Journal of Molecular Neuroscience
26. Protection against the synaptic targeting and toxicity of Alzheimer's‐associated Aβ oligomers by insulin mimetic chiro‐inositols
    Jason E. Pitt, Michael O. Thorner, David L. Brautigan, Joseph Larner, William L. Klein · 2012 · The FASEB Journal
27. Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer’s Disease
    Waqar Ahmad, Paul R. Ebert · 2016 · Molecular Neurobiology
28. Insulin/IGF Signaling-Related Gene Expression in the Brain of a Sporadic Alzheimer's Disease Monkey Model Induced by Intracerebroventricular Injection of Streptozotocin
    Youngjeon Lee, Young-Hyun Kim, Sang-Je Park, Jae‐Won Huh, Sang‐Hyun Kim, Sun‐Uk Kim, Jisu Kim, Kang-Jin Jeong, Kyoungmin Lee, Yonggeun Hong et al. · 2013 · Journal of Alzheimer s Disease
29. Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits
    Jim R. Fadel, Lawrence Patrick Reagan · 2015 · Current Opinion in Behavioral Sciences
30. T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer’s Disease
    Ming Tong, Chetram Deochand, John R. Didsbury, Suzanne M. de la Monte · 2016 · Journal of Alzheimer s Disease
31. Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation
    Sisi Yang, Zhe Chen, Ming Cao, Renjie Li, Zhigang Wang, Muxun Zhang · 2017 · Molecular Medicine Reports
32. Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction
    Noriyasu Kamei, Nobuyuki Okada, Takamasa Ikeda, Hayoung Choi, Yui Fujiwara, Haruka Okumura, Mariko Takeda‐Morishita · 2018 · Scientific Reports
33. Targeting Insulin Resistance to Treat Cognitive Dysfunction
    Anit Tyagi, Subbiah Pugazhenthi · 2021 · Molecular Neurobiology
34. Protective Effects of Curcumin on Amyloid-β-Induced Neuronal Oxidative Damage
    Han‐Chang Huang, Ping Chang, Xueling Dai, Zhao-Feng Jiang · 2012 · Neurochemical Research
35. Curcumin regulates insulin pathways and glucose metabolism in the brains of APPswe/PS1dE9 mice
    Pengwen Wang, Caixin Su, Huili Feng, Xiaopei Chen, Yunfang Dong, Yingxue Rao, Ying Ren, Jin-Duo Yang, Jing Shi, Jinzhou Tian et al. · 2017 · International Journal of Immunopathology and Pharmacology
36. Emerging role of amyloid beta in stress response: Implication for depression and diabetes
    Maria Grazia Morgese, Stefania Schiavone, Luigia Trabace · 2017 · European Journal of Pharmacology
37. Insulin and leptin as potential cognitive enhancers in metabolic disorders and Alzheimer's disease
    Diana C.P. Mejido, Julyanna A. Peny, Marcelo N. N. Vieira, Sergio Teixeira Ferreira, Fernanda G. De Felice · 2020 · Neuropharmacology
38. Aβ1–42 reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: A quantitative analysis
    Nicholas A. Evans, Laura Facci, Davina E. OWEN, Peter E. Soden, Stephen A. Burbidge, Rab K. Prinjha, Jill C. Richardson, Stephen D. Skaper · 2008 · Journal of Neuroscience Methods
39. Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons
    Giuffrida, Maria L., Tomasello, Marianna F., Pandini, Giuseppe, Caraci, Filippo, Battaglia, Giuseppe, Busceti, Carla, Di Pietro, Paola, Pappalardo, Giuseppe, Attanasio, Francesco, Chiechio, Santina et al. · 2015 · Frontiers in Cellular Neuroscience
40. Biliverdin reductase-A impairment links brain insulin resistance with increased Aβ production in an animal model of aging: Implications for Alzheimer disease
    Francesca Triani, Antonella Tramutola, Fabio Di Domenico, Nidhi Krishan Sharma, David Allan Butterfield, Elizabeth Head, Marzia Perluigi A, Eugenio Barone · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
41. Calcium-Sensing Receptors of Human Neural Cells Play Crucial Roles in Alzheimer's Disease
    Chiarini, Anna, Armato, Ubaldo, Liu, Daisong, Dal Prà, Ilaria · 2016 · Frontiers in Physiology
42. Impaired Insulin Signaling and Mechanisms of Memory Loss
    Jenna Bloemer, Subhrajit Bhattacharya, Rajesh Amin, Vishnu D. Suppiramaniam · 2014 · Progress in molecular biology and translational science
43. Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain
    Aarti N. Patel, Jack H. Jhamandas · 2012 · Expert Reviews in Molecular Medicine
44. Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse
    Noriyasu Kamei, Misa Tanaka, Hayoung Choi, Nobuyuki Okada, Takamasa Ikeda, Rei Itokazu, Mariko Takeda‐Morishita · 2017 · Molecular Pharmaceutics
45. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease
    Dustin T. Proctor, Elizabeth Jane Coulson, Peter Ronald Dodd · 2011 · Progress in Neurobiology
46. Allosteric function and dysfunction of the prion protein
    Rafael Linden, Yraima Cordeiro, Luís Maurício T. R. Lima · 2011 · Cellular and Molecular Life Sciences
47. Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
    Jeffrey L. Cummings, Andrew Adonay Ortiz, Janelle Castellino, Jefferson W. Kinney · 2022 · European Journal of Neuroscience
48. Amyloid β precursor protein as a molecular target for amyloid β–induced neuronal degeneration in Alzheimer's disease
    Elena Anahí Bignante, Florencia Heredia, Gerardo A. Morfini, Alfredo Lorenzo · 2013 · Neurobiology of Aging
49. Shared Genetic Etiology between Type 2 Diabetes and Alzheimer’s Disease Identified by Bioinformatics Analysis
    Lei Gao, Zhen Cui, Liang Shen, Hong‐Fang Ji · 2016 · Journal of Alzheimer s Disease
50. The rise and fall of insulin signaling in Alzheimer’s disease
    Belal Chami, Ariah J. Steel, Suzanne M. de la Monte, Greg Trevor Sutherland · 2016 · Metabolic Brain Disease
51. Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease
    Ana Isabel Duarte, Maria S. Santos, Catarina Resende Oliveira, Paula Isabel Moreira · 2018 · Neuropharmacology
52. Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
    Reich, Niklas, Hölscher, Christian · 2020 · Frontiers in Neuroscience
53. Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease
    Priyanka Madhu, Samrat Mukhopadhyay · 2021 · Journal of Cellular Biochemistry
54. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer’s Disease Pathology: Evidence from In Vitro and In Vivo Studies
    Smriti Nagpal Gupta, Vishal Singh, Subramaniam Ganesh, Nitin Kumar Singhal, Rajat Sandhir · 2021 · ACS Applied Materials & Interfaces
55. Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
    Kerstin T.S. Wirz, Stella Keitel, Dick Frans Swaab, Joost Verhaagen, Koen Bossers · 2013 · Journal of Alzheimer s Disease
56. Eph receptors: New players in Alzheimer's disease pathogenesis
    Moustapha Cissé, Frédéric Checler · 2014 · Neurobiology of Disease
57. Diabetes Mellitus Accelerates Aβ Pathology in Brain Accompanied by Enhanced GAβ Generation in Nonhuman Primates
    Sachi Okabayashi, Nobuhiro Shimozawa, Yasuhiro Yasutomi, Katsuhiko Yanagisawa, Nobuyuki Kimura · 2015 · PLoS ONE
58. Modulation of Skeletal Muscle Insulin Signaling With Chronic Caloric Restriction in Cynomolgus Monkeys
    Zhong Q. Wang, Z. Elizabeth Floyd, Jianhua Qin, Xiaotuan Liu, Yongmei Yu, Xian H. Zhang, Janice D. Wagner, William T. Cefalu · 2009 · Diabetes
59. S14G‐humanin alleviates insulin resistance and increases autophagy in neurons of APP/PS1 transgenic mouse
    Kun Han, Ning Jia, Yi Zhong, Xiuli Shang · 2017 · Journal of Cellular Biochemistry
60. Diabetes and neurodegeneration in the brain
    Cory C. Toth · 2014 · Handbook of clinical neurology
61. Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine
    Dorothy G. Flood, Gerard J. Marek, Michael J. Williams · 2011 · Biochemical Pharmacology
62. Amyloid-β Protein Modulates Insulin Signaling in Presynaptic Terminals
    David Heras-Sandoval, Patricia Ferrera, Clorinda Arias · 2012 · Neurochemical Research
63. Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?
    Maud Gratuze, Aurélie Joly‐Amado, Didier Vieau, Luc Buée, David L Blum · 2018 · Neuroendocrinology
64. Crucial players in Alzheimer’s disease and diabetes mellitus: Friends or foes?
    Adriana Kubis-Kubiak, Anna Rorbach-Dolata, Agnieszka Piwowar · 2019 · Mechanisms of Ageing and Development
65. Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides
    Jeehye Maeng, Kyunglim Lee · 2022 · Frontiers in Pharmacology
66. Inflammatory risk factors and pathologies promoting Alzheimer's disease progression: is RAGE the key?
    Carmela Matrone, Mehdi Djelloul, Giulio Taglialatela, Lorena Perrone · 2015 · PubMed
67. β-amyloid and Oxidative Stress: Perspectives in Drug Development
    Giuseppe Caruso, Simona Federica Spampinato, Vincenzo Cardaci, Filippo Caraci, Maria Angela Sortino, Sara Merlo · 2019 · Current Pharmaceutical Design
68. Insulin induces phosphorylation of the AMPA receptor subunit GluR1, reversed by ZIP, and over‐expression of Protein Kinase M zeta, reversed by amyloid beta
    Linda Adzovic, Luciano Domenici · 2014 · Journal of Neurochemistry
69. Insulin Promotes Survival of Amyloid-Beta Oligomers Neuroblastoma Damaged Cells via Caspase 9 Inhibition and Hsp70 Upregulation
    Marta Di Carlo, Pasquale Picone, Rita Carrotta, Daniela Giacomazza, Pier Luigi San Biagio · 2010 · BioMed Research International
70. Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Dise ase Pathologies
    Ming Tong, Cesar Dominguez · 2016 · Journal of Alzheimer’s Disease & Parkinsonism
71. Reduced brain insulin signaling: A seminal process in Alzheimer's disease pathogenesis
    Bloom, George S., Lazo, John S., Norambuena, Andrés · 2018 · Neuropharmacology
72. Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice
    Chelsea M. Griffith, Lauren N. Macklin, Yan Cai, Andrew A. Sharp, Xiao‐Xin Yan, Lawrence Patrick Reagan, April D. Strader, Gregory M. Rose, Peter R. Patrylo · 2019 · Journal of Alzheimer s Disease
73. Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses
    Nicholas G. Norwitz, Adrián Soto-Mota, Sam G. Norwitz, Kieran Clarke · 2019 · Frontiers in Aging Neuroscience
74. Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain
    the Cognitive Function and Ageing Study, Joanna J. Bury, Annabelle Chambers, Paul Roy Heath, Paul G. Ince, Pamela J. Shaw, Fiona E. Matthews, Carol Brayne, Julie E. Simpson, Stephen B. Wharton · 2021 · Acta Neuropathologica Communications
75. Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice
    Shaoyu Zhou, Feng Jie Jin, Fei Yan, Ju Liu, Meixiang Chen, Ying Zhang, Sheng-Jiao Wei, Hai Dan Jin, Jing Nie, Xiao-Long Fu et al. · 2022 · Neural Regeneration Research
76. Amyloid β Dodecamer Disrupts the Neuronal Membrane More Strongly than the Mature Fibril: Understanding the Role of Oligomers in Neurotoxicity
    Hoang Linh Nguyen, Huynh Quang Linh, Paweł Krupa, Giovanni La Penna, Mai Suan Li · 2022 · The Journal of Physical Chemistry B
77. Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells
    Seung‐Yong Yoon, Jeong-Su Park, Jung‐Eun Choi, Jin-Myung Choi, Woo-Je Lee, Seong-Who Kim, Dong‐Hou Kim · 2010 · Neurobiology of Disease
78. Alzheimer’s disease: amyloid-based pathogenesis and potential therapies
    Yixiu Zhou, Yuhui Sun, Quanhong Ma, Yaobo Liu · 2018 · Cell Stress
79. Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer’s Disease and Brain Insulin Resistance, and Its Relation to Cancer
    M. Murat Köseoğlu, Andrés Norambuena, Elizabeth R. Sharlow, John Stephen Lazo, George S. Bloom · 2018 · Journal of Alzheimer s Disease
80. Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions
    Помыткин Игорь Анатольевич, Vsevolod G. Pinelis · 2021 · Life
81. Pharmacological relevance of CDK inhibitors in Alzheimer's disease
    Nishtha Malhotra, Rohan V. Gupta, Pravir Kumar · 2021 · Neurochemistry International
82. Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning
    Sze Chung Yuen, Xiaonan Liang, Hongmei Zhu, Yongliang Jia, Siu-wai Leung · 2021 · Alzheimer s Research & Therapy
83. Early-Life Environment Influence on Late-Onset Alzheimer’s Disease
    Thibaut Gauvrit, Hamza Benderradji, Luc Buée, David L Blum, Didier Vieau · 2022 · Frontiers in Cell and Developmental Biology
84. Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies
    Xiangyuan Meng, Hui Zhang, Zhenhu Zhao, Siyao Li, Xin Zhang, Ruihan Guo, Hui Li, Yiling Yuan, W Li, Qi Song et al. · 2025 · Molecular Medicine
85. Effect of sitagliptin on the working memory and reference memory in type 2 diabetic Sprague-Dawley rats: possible role of adiponectin receptors 1.
    H F Sakr · 2013 · PubMed
86. Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms
    Kashif Abbas, Mohd Mustafa, Mudassir Alam, Safia Habib, Waleem Ahmad, Mohd Adnan, Md. Imtaiyaz Hassan, Nazura Usmani · 2025 · Neurogenetics
87. Regulated Proteolysis of RAGE and AβPP as Possible Link Between Type 2 Diabetes Mellitus and Alzheimer's Disease
    E. Kojro, R. Postina · 2009 · Journal of Alzheimer's Disease
88. Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease
    Melinda Urkon, Elek Ferencz, József Attila Szász, Monica Iudita Maria Szabó, Károly Orbán-Kis, Szabolcs Szatmári, Előd Ernő Nagy · 2025 · Pharmaceuticals
89. ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing Aβ impairment of insulin signaling in an Alzheimer’s disease mouse model
    Chan, Elizabeth S., Shetty, Mahesh Shivarama, Sajikumar, Sreedharan, Chen, Christopher, Soong, Tuck Wah, Wong, Boon-Seng · 2016 · Scientific Reports
90. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes
    Carmen Infante‐Garcia, Juan José Ramos‐Rodríguez, Carmen Hierro‐Bujalance, Esperanza Ortegon, Eleanor K. Pickett, Rosemary J. Jackson, Fernando Hernandez Pacho, Tara L. Spires‐Jones, Mónica Garcı́a-Alloza · 2017 · Molecular Neurobiology
91. Excitotoxic glutamate causes neuronal insulin resistance by inhibiting insulin receptor/Akt/mTOR pathway
    Помыткин Игорь Анатольевич, Irina A. Krasilnikova, Бакаева Занда Валериевна, Alexander M. Surin, Vsevolod G. Pinelis · 2019 · Molecular Brain
92. Navigating the intersection: Diabetes and Alzheimer's intertwined relationship
    Mayur Bhimrao Kale, Harshavardhan M Bhondge, Nitu L. Wankhede, Prajwali V Shende, Rushikesh Thanekar, Manish Manohar Aglawe, Sandip R. Rahangdale, Brijesh Gulabrao Taksande, Sunil B. Pandit, Aman Babanrao Upaganlawar et al. · 2024 · Ageing Research Reviews
93. Reciprocal Molecular Interactions between the Aβ Peptide Linked to Alzheimer’s Disease and Insulin Linked to Diabetes Mellitus Type II
    Jinghui Luo, Sebastian K.T.S. Wärmländer, Astrid Gräslund, Jan Pieter Abrahams · 2016 · ACS Chemical Neuroscience
94. A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer’s Disease and Type 2 Diabetes Mellitus
    A. Kaminari, E. C. Tsilibary, A. Tzinia · 2018 · Journal of Alzheimer's Disease
95. Mini‐review: Role of the PI3K/Akt pathway and tyrosine phosphatases in Alzheimer's disease susceptibility
    David Curtis, Sreejan Bandyopadhyay · 2020 · Annals of Human Genetics
96. Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses
    Suélen Santos Alves, Rui Milton Patrício da Silva-Júnior, Gabriel Servilha‐Menezes, Jan Homolak, Melita Šalković‐Petrišić, Norberto Garcia‐Cairasco · 2021 · Journal of Alzheimer s Disease
97. Influence of genetic and cardiometabolic risk factors in Alzheimer’s disease
    Giuseppe Pasqualetti, Tony Thayanandan, Paul Edison · 2022 · Ageing Research Reviews
98. Advances on the Understanding of the Origins of Synaptic Pathology in AD
    Pascale N. Lacor · 2007 · Current Genomics
99. Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer’s Disease
    Ari Robinson, Irit Lubitz, Dana Atrakchi, Avital Licht-Murava, Pavel Katsel, Derek LeRoith, Sigal Liraz Zaltsman, Vahram H. Haroutunian, Michal Schnaider Beeri · 2019 · Journal of Molecular Neuroscience
100. Metabolic Syndrome: Is It Time to Add the Central Nervous System?
     Milagros Rojas, Mervin Chávez-Castillo, Daniela Pírela, Heliana Parra, Manuel Nava, Maricarmen Chacín, Lissé Angarita, Roberto Áñez, Juan José Salazar, Rina Ortíz et al. · 2021 · Nutrients